Literature DB >> 28917252

Stereotactic radiosurgery of the brain: a review of common indications.

Philip Gilbo1, Isabella Zhang2, Jonathan Knisely2.   

Abstract

Over the past half-century since Lars Leksell first utilized radiation to address deep and difficult to treat lesions of the central nervous system (CNS), intracranial stereotactic radiosurgery (SRS) has become an increasingly valued tool in the hands of neurosurgeons and radiation oncologists. Following developments in medical imaging and radiation technology, radiosurgery has evolved from its first application in movement disorders to widespread use for a varied range of malignant and benign conditions. SRS remains a powerful, minimally invasive instrument that offers additional options for intervention to a diverse patient population. In this review, we will touch upon the common indications for SRS, including its use in brain metastases, malignant gliomas, meningiomas, arteriovenous malformations (AVMs), vestibular schwannomas, pituitary adenomas, and functional disorders, as well as consider the future possibilities of combining radiosurgery with immunotherapy.

Entities:  

Keywords:  Intracranial SRS; SRS review; stereotactic radiosurgery (SRS)

Mesh:

Year:  2017        PMID: 28917252     DOI: 10.21037/cco.2017.06.07

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  8 in total

1.  Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT.

Authors:  Paul Retif; Abdourahamane Djibo Sidikou; Christian Mathis; Romain Letellier; Emilie Verrecchia-Ramos; Rémi Dupres; Xavier Michel
Journal:  Strahlenther Onkol       Date:  2022-08-18       Impact factor: 4.033

2.  Quantification of hemodynamics of cerebral arteriovenous malformations after stereotactic radiosurgery using 4D flow magnetic resonance imaging.

Authors:  Shanmukha Srinivas; Tara Retson; Aaron Simon; Jona Hattangadi-Gluth; Albert Hsiao; Nikdokht Farid
Journal:  J Magn Reson Imaging       Date:  2020-12-22       Impact factor: 5.119

Review 3.  Effects of Radiation Therapy on Neural Stem Cells.

Authors:  Anna Michaelidesová; Jana Konířová; Petr Bartůněk; Martina Zíková
Journal:  Genes (Basel)       Date:  2019-08-24       Impact factor: 4.096

4.  Locomotion and eating behavior changes in Yucatan minipigs after unilateral radio-induced ablation of the caudate nucleus.

Authors:  Nicolas Coquery; Jean-François Adam; Christian Nemoz; Régis Janvier; Jayde Livingstone; Alain Chauvin; Samy Kefs; Cécile Guerineau; Loic De Saint Jean; Alexandre Ocadiz; Audrey Bouchet; Stefan Bartzsch; Elisabeth Schültke; Albert Siegbahn; Elke Bräuer-Krisch; Benjamin Lemasson; Emmanuel Luc Barbier; Jean Laissue; Jacques Balosso; David Val-Laillet; Raphael Serduc
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

5.  Frameless radiosurgical third ventriculostomy: Technical report.

Authors:  Guillermo Axayacalt Gutierrez-Aceves; Alejandro Rodriguez-Camacho; Miguel Angel Celis-Lopez; Sergio Moreno-Jimenez; Jose Alfredo Herrera-Gonzalez
Journal:  Surg Neurol Int       Date:  2020-11-18

6.  Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy.

Authors:  Rahul N Prasad; Vedat O Yildiz; Tejash Patel; Trevor J Royce; Joshua D Palmer
Journal:  Adv Radiat Oncol       Date:  2021-10-26

7.  The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers.

Authors:  Xuexue Bai; Meng Zhou
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

8.  Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD.

Authors:  Katja Hatz; Frank Zimmermann; Emmanouil Lazaridis; Dimitrios Kardamakis; Magdalena Guichard; Cengiz Türksever; Christian Pruente; Ursula Margarethe Schmidt-Erfurth; Bianca S Gerendas
Journal:  Br J Ophthalmol       Date:  2020-12-21       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.